Odyssey Health, Inc. financial data

Symbol
ODYY on OTC
Location
2300 West Sahara Avenue, Suite 800 #4012, Las Vegas, NV
Fiscal year end
July 31
Latest financial report
10-K - Q2 2025 - Oct 29, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.5 % -65.5%
Return On Equity 26.4 %
Return On Assets -848 % -7154%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 99.9M shares +3.25%
Common Stock, Shares, Outstanding 96.7M shares 0%
Entity Public Float 1.77M USD -74.3%
Common Stock, Value, Issued 96.7K USD 0%
Weighted Average Number of Shares Outstanding, Basic 105M shares +7.88%
Weighted Average Number of Shares Outstanding, Diluted 105M shares +7.88%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 0 USD -100%
General and Administrative Expense 1.02M USD -51%
Operating Income (Loss) -1.02M USD +52.3%
Net Income (Loss) Attributable to Parent -1.74M USD -107%
Earnings Per Share, Basic 0 USD/shares -100%
Earnings Per Share, Diluted 0 USD/shares -100%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 3.19K USD -95.2%
Assets, Current 49.7K USD -12.7%
Assets 49.7K USD -91.5%
Accounts Payable, Current 1.62M USD +15.3%
Accrued Liabilities, Current 13.8K USD 0%
Liabilities, Current 7M USD +18.3%
Retained Earnings (Accumulated Deficit) -62.7M USD -2.86%
Stockholders' Equity Attributable to Parent -6.95M USD -30.4%
Liabilities and Equity 49.7K USD -91.5%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -249K USD -315%
Net Cash Provided by (Used in) Financing Activities 300K USD +35.8%
Net Cash Provided by (Used in) Investing Activities 0 USD
Common Stock, Shares Authorized 500M shares 0%
Common Stock, Shares, Issued 96.7M shares 0%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 19.1K USD +702%
Interest Paid, Excluding Capitalized Interest, Operating Activities 705 USD +28.4%
Deferred Tax Assets, Valuation Allowance 12.5M USD +2.23%
Deferred Tax Assets, Gross 12.5M USD +2.23%
Deferred Tax Assets, Operating Loss Carryforwards 4.23M USD +18.8%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 100M shares 0%
Unrecognized Tax Benefits 0 USD
Additional Paid in Capital 55.7M USD +0.22%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 1.54K USD -55%
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Interest Expense 594K USD -6.16%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%